Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children.

ABSTRACT:

Objectives

To evaluate the safety and clinical outcome of bleomycin electrosclerotherapy (BEST) for treating extracranial slow-flow malformations.

Methods

In this retrospective investigation of a multicenter cohort presenting symptomatic slow-flow malformations, patient records were analyzed with respect to procedural details and complications. A treatment-specific, patient-reported questionnaire was additionally evaluated, obtained 3-12 months after the last treatment, to assess the subjective outcomes, including mobility, aesthetic aspects, and pain, as well as the occurrence of postprocedural skin hyperpigmentation. All outcome parameters were compared according to patients' age.

Results

Overall, 325 BEST treatments were performed in 233 patients after intralesiona

SUBMITTER: Schmidt VF 

PROVIDER: S-EPMC11399160 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature